{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:10Z","timestamp":1777374370535,"version":"3.51.4"},"reference-count":13,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,7,12]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>A 26-year-old Caucasian male patient with a history of cystic fibrosis presented with a 6-month history of diffuse joint pain and swelling. He was found to have active synovitis in bilateral wrists and proximal interphalangeal joints of the hands on physical examination. He was diagnosed with seropositive rheumatoid arthritis since he had positive anti-cyclic citrullinated peptide antibodies and erosions on hand and foot X-rays. The patient has responded well to abatacept which may have less infection risk compared with other biological therapies.<\/jats:p>","DOI":"10.1136\/bcr-2020-234305","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T03:31:34Z","timestamp":1599449494000},"page":"e234305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Rheumatoid arthritis in a patient with cystic fibrosis: challenging treatment options"],"prefix":"10.1136","volume":"13","author":[{"given":"Kelly Lynn","family":"Delaney-Nelson","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Missouri Health System, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena Marie","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Missouri Health System, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chokkalingam","family":"Siva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Missouri Health System, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,9,6]]},"reference":[{"key":"2025082711334586000_13.9.e234305.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(03)00063-0"},{"key":"2025082711334586000_13.9.e234305.2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/1529-0131(199908)42:8<1563::AID-ANR1>3.0.CO;2-H","article-title":"Rheumatic disease and cystic fibrosis","volume":"42","author":"Merkel","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2025082711334586000_13.9.e234305.3","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jcf.2015.12.022","article-title":"Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy","volume":"15","author":"Fitch","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2025082711334586000_13.9.e234305.4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.39399","article-title":"Comparative risk of hospitalized infection associated with biologic agents in rheumatoid arthritis patients enrolled in Medicare","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025082711334586000_13.9.e234305.5","doi-asserted-by":"crossref","unstructured":"Chen SK , Liao KP , Liu J , et al . Risk of hospitalized infection and initiation of abatacept versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis: a propensity score-matched cohort study. Arthritis Care Res 2018.","DOI":"10.1136\/annrheumdis-2018-eular.2003"},{"key":"2025082711334586000_13.9.e234305.6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-019-1921-z","article-title":"Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study","volume":"21","author":"Ozen","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025082711334586000_13.9.e234305.7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/M18-2217","article-title":"Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty: a cohort study","volume":"170","author":"George","year":"2019","journal-title":"Ann Intern Med"},{"key":"2025082711334586000_13.9.e234305.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.01.009"},{"key":"2025082711334586000_13.9.e234305.9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-012-9393-9","article-title":"Improvements in cystic fibrosis lung disease and airway inflammation associated with etanercept therapy for rheumatoid arthritis: a case report","volume":"190","author":"Visser","year":"2012","journal-title":"Lung"},{"key":"2025082711334586000_13.9.e234305.10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/03009742.2015.1122834","article-title":"Safe and effective tumour necrosis factor-\u03b1 inhibitor (etanercept) treatment of chronic episodic arthritis in a patient with cystic fibrosis","volume":"45","author":"Adelsten","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"2025082711334586000_13.9.e234305.11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00408-009-9138-6","article-title":"Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumor necrosis factor alpha","volume":"187","author":"Casserly","year":"2009","journal-title":"Lung"},{"key":"2025082711334586000_13.9.e234305.12","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1980.02130150073019"},{"key":"2025082711334586000_13.9.e234305.13","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/28.2.179","article-title":"Cystic fibrosis and rheumatoid arthritis","volume":"28","author":"Gardiner","year":"1989","journal-title":"Br J Rheumatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-234305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:33:53Z","timestamp":1756319633000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-234305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,6]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bcr-2020-234305"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-234305","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}